A randomised trial of enteral glutamine supplementation for very preterm children showed no beneficial or adverse long-term neurodevelopmental outcomes
Acta Pediatrica Dec 02, 2017
Twilhaar ES, et al. - This study was formulated in order to contemplate the long-term effects of enteral glutamine supplementation on neurodevelopmental outcomes of a Dutch cohort of very preterm children at 13 years of age. No evidence was yielded with regard to the enteral glutamine supplementation exhibiting any beneficial or adverse effects on the children's motor, neurocognitive, academic and behavioural outcomes at 13 years of age.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries